Clinical Trial Update: A Dose Escalating Study of HC002 in Healthy Adult Volunteers [Phase 1]

View source ↗

Summary

This update reports the completion of a Phase 1 dose-escalation study of the investigational asset HC002 in healthy adult volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Diseases
• Inflammatory Diseases

Drugs mentioned

• HC002

Snippet

Sponsor: Holoclara Aus Pty Ltd | Conditions: Inflammatory Disease, Autoimmune Diseases | Phase 1 | Status: COMPLETED